Maternal COVID-19 vaccine acceptance among Malaysian pregnant women: A multicenter cross-sectional study

Aida Kalok1, Wira Razak Dali1, Shalisah Sharip2

  • 1Department of Obstetrics and Gynaecology, Faculty of Medicine, National University of Malaysia, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.

Insights

Maternal vaccine acceptance for COVID-19 was 77.1% in Malaysian pregnant women. Factors like income, employment, and reliable information sources influenced acceptance, highlighting the need for professional guidance to reduce hesitancy.

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • The COVID-19 pandemic significantly impacted global health and economies.
  • Pregnant women face increased risks for severe COVID-19 complications due to physiological changes.
  • Assessing vaccine acceptance among pregnant populations is crucial for public health strategies.

Purpose of the Study:

  • To evaluate the acceptance rate of the COVID-19 vaccine among pregnant women in Malaysia.
  • To identify factors influencing maternal vaccine acceptance and hesitancy.

Main Methods:

  • A multi-center survey was conducted in four teaching hospitals in Klang Valley, Malaysia.
  • Self-administered electronic questionnaires assessed perceptions, attitudes, and anxiety related to COVID-19 vaccination.
  • Data from 1,272 pregnant women were analyzed.

Main Results:

  • Maternal vaccine acceptance for COVID-19 was 77.1%.
  • Positive predictors included higher income, employment, being a health sector worker, personal/social infection history, and pregnancy-related anxiety.
  • Reliance on internet/social media for information correlated with higher acceptance.

Conclusions:

  • High maternal vaccine acceptance in urban Malaysian pregnant women may be linked to socio-economic status.
  • Responsible use of online information and professional health counseling are key to addressing vaccine hesitancy.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
45.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
397
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
25
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K